HMGCS1 and acute myeloid leukemia: http://links.lww.com/BS/A98 To explore whether inhibition of HMGCS1 with its inhibitor hymeglusin is feasible for AML treatment, we further examined the inhibitory effects of hymeglusin in primary bone marrow samples.